RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer

Por Ahlers, Katelin E., Chakravarti, Bandana, Fisher, Rory A.
Publicado no AAPS J (2016)

Transient activation of microglia following acute alcohol exposure in developing mouse neocortex is primarily driven by BAX-dependent neurodegeneration

Por Ahlers, Katelin E., Karaçay, Bahri, Fuller, Leah, Bonthius, Daniel J., Dailey, Michael E.
Publicado no Glia (2015)

“P2X7 Receptor Activation Regulates Microglial Cell Death During Oxygen-Glucose Deprivation”

Por Eyo, Ukpong B., Miner, Sam A., Ahlers, Katelin E., Wu, Long-Jun, Dailey, Michael E.
Publicado em 2013

RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation

Por Yang, Jianqi, Platt, Lance T., Maity, Biswanath, Ahlers, Katelin E., Luo, Zili, Lin, Zhibo, Chakravarti, Bandana, Ibeawuchi, Stella-Rita, Askeland, Ryan W., Bondaruk, Jolanta, Czerniak, Bogdan A., Fisher, Rory A.
Publicado no Oncotarget (2016)